Dr. Connolly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1Tower Place
#300
South San Francisco, CA 94080- Is this information wrong?
Education & Training
- University of WashingtonFellowship, Infectious Disease, 2003 - 2005
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2001 - 2003
- University of California San Francisco School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2002 - 2024
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 8 citationsARGONAUT II Study of the In Vitro Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniae.Michael R. Jacobs, Caryn E. Good, Andrea M. Hujer, Ayman M. Abdelhamed, Daniel D. Rhoads, Kristine M. Hujer, Susan D. Rudin, T. Nicholas Domitrovic, Lynn E. Connolly, ...> ;Antimicrobial Agents and Chemotherapy. 2020 Apr 21
- 124 citationsPlazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.James A. McKinnell, Jamie P. Dwyer, George H. Talbot, Lynn E. Connolly, Ian R. Friedland, Alexander K. Smith, Adrian Jubb, Alisa W Serio, Kevin M. Krause, George L. Da...> ;The New England Journal of Medicine. 2019 Feb 20
- 113 citationsOnce-Daily Plazomicin for Complicated Urinary Tract Infections.Florian M.E. Wagenlehner, Daniel J. Cloutier, Allison Seiko Komirenko, Deborah S Cebrik, Kevin M. Krause, Tiffany R. Keepers, Lynn E. Connolly, Loren G. Miller, Ian Fr...> ;The New England Journal of Medicine. 2019 Feb 20
- Join now to see all
Press Mentions
- Adagio Therapeutics Launches with $50M Series A Financing to Advance the Development of Best-in-Class, Broadly Neutralizing Antibodies for Coronavirus Treatment and ProphylaxisJuly 16th, 2020
Grant Support
- Biofilm Formation In Mycobacterial Persistence And Drug Tolerance In VivoNational Institute Of Allergy And Infectious Diseases2008–2010
- Biofilm Formation In Mycobacterial Persistence And Drug Tolerance In VivoNational Institute Of Allergy And Infectious Diseases2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: